Nina Wettschureck and Stefan Offermanns - Physiological Reviews

More documents

Recommendations

Info

1194 NINA WETTSCHURECK AND STEFAN OFFERMANNS 329. Kehlenbach RH, Matthey J, and Huttner WB. XL alpha s is a new type of G protein. Nature 372: 804–809, 1994. 330. Keverne EB. The vomeronasal organ. Science 286: 716–720, 1999. 331. Keys JR, Greene EA, Koch WJ, and Eckhart AD. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature. Hypertension 40: 660–666, 2002. 332. Kieffer TJ. GIP or not GIP? That is the question. Trends Pharmacol Sci 24: 110–112, 2003. 333. Kifor O, Diaz R, Butters R, and Brown EM. The Ca 2� -sensing receptor (CaR) activates phospholipases C, A 2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 12: 715–725, 1997. 334. Kim IS, Kim ER, Nam HJ, Chin MO, Moon YH, Oh MR, Yeo UC, Song SM, Kim JS, Uhm MR, Beck NS, and Jin DK. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res 52: 235–240, 1999. 335. Kishi K, Hayashi H, Wang L, Kamohara S, Tamaoka K, Shimizu T, Ushikubi F, Narumiya S, and Ebina Y. Gq-coupled receptors transmit the signal for GLUT4 translocation via an insulin-independent pathway. J Biol Chem 271: 26561–26568, 1996. 336. Kishi K, Muromoto N, Nakaya Y, Miyata I, Hagi A, Hayashi H, and Ebina Y. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 47: 550–558, 1998. 337. Klages B, Brandt U, Simon MI, Schultz G, and Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinasemediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 144: 745–754, 1999. 338. Klemke M, Kehlenbach RH, and Huttner WB. Two overlapping reading frames in a single exon encode interacting proteins–a novel way of gene usage. EMBO J 20: 3849–3860, 2001. 339. Klemke M, Pasolli HA, Kehlenbach RH, Offermanns S, Schultz G, and Huttner WB. Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties. J Biol Chem 275: 33633–33640, 2000. 340. Kleppisch T, Voigt V, Allmann R, and Offermanns S. G(alpha)qdeficient mice lack metabotropic glutamate receptor-dependent long-term depression but show normal long-term potentiation in the hippocampal CA1 region. J Neurosci 21: 4943–4948, 2001. 341. Knowlton KU, Michel MC, Itani M, Shubeita HE, Ishihara K, Brown JH, and Chien KR. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 268: 15374–15380, 1993. 342. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656–660, 1999. 343. Korbonits M, Goldstone AP, Gueorguiev M, and Grossman AB. Ghrelin—a hormone with multiple functions. Front Neuroendocrinol 25: 27–68, 2004. 344. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, and Kohn LD. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3�,5�-cyclic adenosine monophosphate signal generation. Mol Endocrinol 7: 1009–1020, 1993. 345. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brezillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, and Parmentier M. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276: 34631–34636, 2001. 346. Kotarsky K, Nilsson NE, Flodgren E, Owman C, and Olde B. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem Biophys Res Commun 301: 406– 410, 2003. 347. Kozasa T. Mechanism of beta-gamma effector interaction. In: Handbook of Cell Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA: Academic, 2004, p. 639–643. 348. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, and Sternweis PC. p115 RhoGEF, a GTPase Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org activating protein for Galpha12 and Galpha13. Science 280: 2109– 2111, 1998. 349. Krapivinsky G, Krapivinsky L, Wickman K, and Clapham DE. G beta gamma binds directly to the G protein-gated K � channel, IKACh. J Biol Chem 270: 29059–29062, 1995. 350. Krause M, Offermanns S, Stocker M, and Pedarzani P. Functional specificity of G alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium currents and excitability in hippocampal neurons. J Neurosci 22: 666–673, 2002. 351. Kreuzer J, Nurnberg B, and Krieger-Brauer HI. Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins. Biochem J 380: 831–836, 2004. 352. Krispel CM, Chen CK, Simon MI, and Burns ME. Prolonged photoresponses and defective adaptation in rods of Gbeta5 �/� mice. J Neurosci 23: 6965–6971, 2003. 353. Kuang Y, Wu Y, Jiang H, and Wu D. Selective G protein coupling by C-C chemokine receptors. J Biol Chem 271: 3975–3978, 1996. 354. Kunapuli SP, Dorsam RT, Kim S, and Quinton TM. Platelet purinergic receptors. Curr Opin Pharmacol 3: 175–180, 2003. 355. Kunkel EJ and Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1–4, 2002. 356. Kurachi Y, Ito H, Sugimoto T, Katada T, and Ui M. Activation of atrial muscarinic K � channels by low concentrations of beta gamma subunits of rat brain G protein. Pflügers Arch 413: 325–327, 1989. 357. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T, and Yazaki Y. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 96: 293–300, 1995. 358. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, and Yazaki Y. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 Nature 368: 703–710, 1994. 359. Kurose H. Galpha12 and Galpha13 as key regulatory mediator in signal transduction. Life Sci 74: 155–161, 2003. 360. Kuwahara K, Saito Y, Nakagawa O, Kishimoto I, Harada M, Ogawa E, Miyamoto Y, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Tamura N, Ogawa Y, and Nakao K. The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes—possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett 452: 314–318, 1999. 361. Lambright DG. Heterotrimeric G protein signaling at atomic resolution. In: Handbook of Cell Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA: Academic, 2004, p. 575–5579. 362. LaMorte VJ, Thorburn J, Absher D, Spiegel A, Brown JH, Chien KR, Feramisco JR, and Knowlton KU. Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J Biol Chem 269: 13490–13496, 1994. 363. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, and Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696, 1989. 364. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 259: 3–17, 1999. 365. Lang J, Nishimoto I, Okamoto T, Regazzi R, Kiraly C, Weller U, and Wollheim CB. Direct control of exocytosis by receptormediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits. EMBO J 14: 3635–3644, 1995. 366. Lania A, Mantovani G, and Spada A. G protein mutations in endocrine diseases. Eur J Endocrinol 145: 543–559, 2001. 367. Laudanna C, Campbell JJ, and Butcher EC. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science 271: 981–983, 1996. 368. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, and Schultz G. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 93: 116–120, 1996.
369. Laurent E, Mockel J, Van Sande J, Graff I, and Dumont JE. Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol 52: 273–278, 1987. 370. Law PY, Wong YH, and Loh HH. Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389–430, 2000. 371. Lawrence JT and Birnbaum MJ. ADP-ribosylation factor 6 delineates separate pathways used by endothelin 1 and insulin for stimulating glucose uptake in 3T3–L1 adipocytes. Mol Cell Biol 21: 5276–5285, 2001. 372. Le LQ, Kabarowski JH, Weng Z, Satterthwaite AB, Harvill ET, Jensen ER, Miller JF, and Witte ON. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14: 561–571, 2001. 373. Le Y, Murphy PM, and Wang JM. Formyl-peptide receptors revisited. Trends Immunol 23: 541–548, 2002. 374. Leck KJ, Bartlett SE, Smith MT, Megirian D, Holgate J, Powell KL, Matthaei KI, and Hendry IA. Deletion of guanine nucleotide binding protein alpha z subunit in mice induces a gene dose dependent tolerance to morphine. Neuropharmacology 46: 836– 846, 2004. 375. Lee B, Yang C, Chen TH, al-Azawi N, and Hsu WH. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors. Am J Physiol Endocrinol Metab 269: E1095–E1100, 1995. 376. Lee DK, George SR, and O’Dowd BF. Continued discovery of ligands for G protein-coupled receptors. Life Sci 74: 293–297, 2003. 377. Lee H, Liao JJ, Graeler M, Huang MC, and Goetzl EJ. Lysophospholipid regulation of mononuclear phagocytes. Biochim Biophys Acta 1582: 175–177, 2002. 378. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, and Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57: 27– 77, 2005. 379. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, and Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104: 1731–1737, 1999. 380. Levenes C, Daniel H, and Crepel F. Retrograde modulation of transmitter release by postsynaptic subtype 1 metabotropic glutamate receptors in the rat cerebellum. J Physiol 537: 125–140, 2001. 381. Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, and Spiegel AM. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74: 545–556, 1983. 382. Levine MA, Jap TS, and Hung W. Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type Ia. J Pediatr 107: 919–922, 1985. 383. Leypold BG, Yu CR, Leinders-Zufall T, Kim MM, Zufall F, and Axel R. Altered sexual and social behaviors in trp2 mutant mice. Proc Natl Acad Sci USA 99: 6376–6381, 2002. 384. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, and Stanley EF. A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 24: 4070–4081, 2004. 385. Li X and Lim B. RhoGTPases and their role in cancer. Oncol Res 13: 323–331, 2003. 386. Li X, Staszewski L, Xu H, Durick K, Zoller M, and Adler E. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA 99: 4692–4696, 2002. 387. Li Y and Anand-Srivastava MB. Inactivation of enhanced expression of G(i) proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ Res 91: 247–254, 2002. 388. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, and Wu D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287: 1046–1049, 2000. 389. Lin SH and Civelli O. Orphan G protein-coupled receptors: targets for new therapeutic interventions. Ann Med 36: 204–214, 2004. CELLULAR FUNCTIONS OF G PROTEINS 1195 Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org 390. Lincoln TM, Cornwell TL, and Taylor AE. cGMP-dependent protein kinase mediates the reduction of Ca 2� by cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 258: C399–C407, 1990. 391. Lindemann B. Receptors and transduction in taste. Nature 413: 219–225, 2001. 392. Lippert E, Baltensperger K, Jacques Y, and Hermouet S. G alpha16 protein expression is up- and down-regulated following T-cell activation: disruption of this regulation impairs activationinduced cell responses. FEBS Lett 417: 292–296, 1997. 393. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, and Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341: 1731–1736, 1999. 394. Liu J, Erlichman B, and Weinstein LS. The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab 88: 4336–4341, 2003. 395. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, and Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 106: 1167–1174, 2000. 396. Liu J, Yu S, Litman D, Chen W, and Weinstein LS. Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 20: 5808–5817, 2000. 397. Liu L, Schwartz BR, Lin N, Winn RK, and Harlan JM. Requirement for RhoA kinase activation in leukocyte de-adhesion. J Immunol 169: 2330–2336, 2002. 398. Logothetis DE, Kurachi Y, Galper J, Neer EJ, and Clapham DE. The beta gamma subunits of GTP-binding proteins activate the muscarinic K � channel in heart. Nature 325: 321–326, 1987. 399. Lohse MJ. Beta-adrenergic system. In: Encyclopedic Reference of Molecular Pharmacology, edited by Offermanns S and Rosenthal W. Berlin: Springer, 2004, p. 169–172. 400. Lombardi MS, Kavelaars A, and Heijnen CJ. Role and modulation of G protein-coupled receptor signaling in inflammatory processes. Crit Rev Immunol 22: 141–163, 2002. 401. Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, Kimmel AR, and Rondinone CM. On the control of lipolysis in adipocytes. Ann NY Acad Sci 892: 155–168, 1999. 402. Lowry WE and Huang XY. G Protein beta gamma subunits act on the catalytic domain to stimulate Bruton’s agammaglobulinemia tyrosine kinase. J Biol Chem 277: 1488–1492, 2002. 403. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, and Seuwen K. Protonsensing G protein-coupled receptors. Nature 425: 93–98, 2003. 404. Lukashev D, Ohta A, Apasov S, Chen JF, and Sitkovsky M. Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 173: 21–24, 2004. 405. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, and Lefkowitz RJ. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283: 655–661, 1999. 406. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, and McCormick F. Two G protein oncogenes in human endocrine tumors. Science 249: 655–659, 1990. 407. Lyubarsky AL, Naarendorp F, Zhang X, Wensel T, Simon MI, and Pugh EN Jr. RGS9–1 is required for normal inactivation of mouse cone phototransduction. Mol Vis 7: 71–78, 2001. 408. Ma YH, Landis C, Tchao N, Wang J, Rodd G, Hanahan D, Bourne HR, and Grodsky GM. Constitutively active stimulatory G protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3�,5�-monophosphate and insulin secretion. Endocrinology 134: 42–47, 1994. 409. Maejima T, Hashimoto K, Yoshida T, Aiba A, and Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31: 463–475, 2001. 410. Magga JM, Jarvis SE, Arnot MI, Zamponi GW, and Braun JE. Cysteine string protein regulates G protein modulation of N-type calcium channels. Neuron 28: 195–204, 2000.
Page 1 and 2: Mammalian G Proteins and Their Cell
Page 3 and 4: TABLE 1. Physiological ligands of G
Page 5 and 6: TABLE 1—Continued Sensory Stimuli
Page 7 and 8: FIG. 1. Functional cycle of G prote
Page 9 and 10: promoter driving the expression of
Page 11 and 12: FIG. 5.G q/G 11 family G proteins a
Page 13 and 14: G proteins, which mediate bronchoco
Page 15 and 16: lets under physiological and pathol
Page 17 and 18: to mediate these effects. The forme
Page 19 and 20: e attributed to an impaired lipolyt
Page 21 and 22: kocytes (56). Indirect evidence for
Page 23 and 24: A. Visual System The human retina c
Page 25 and 26: addressed the role of G proteins in
Page 27 and 28: C. G i-Mediated Cell Transformation
Page 29 and 30: 45. Berstein G, Blank JL, Jhon DY,
Page 31 and 32: 123. Cyster JG. Chemokines, sphingo
Page 33 and 34: 207. Gehrmann J, Meister M, Maguire
Page 35: 290. Imamura T, Vollenweider P, Ega
Page 39 and 40: Local calcium release in dendritic
Page 41 and 42: 533. Radu CG, Yang LV, Riedinger M,
Page 43 and 44: 616. Suwazono Y, Okubo Y, Kobayashi
Page 45 and 46: 695. Wu D, Huang CK, and Jiang H. R

Nina Wettschureck and Stefan Offermanns - Physiological Reviews

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?